Table 3.
Serological assays | Prevalence, n (%) | 95% CI |
---|---|---|
rK39 ICT | 37 (14.4) | 10.6–19.2 |
p-ELISA | 65 (25.3) | 20.4–30.9 |
IFAT | 47 (18.3) | 14.0–23.5 |
rK39 ICT, p-ELISA and IFAT | 28 (10.9) | 7.6–15.3 |
Positive in at least one test | 75 (29.2) | 24.0–35.0 |
ICT: immunochromatographic test; IFAT: indirect fluorescent antibody test; p-ELISA: enzyme linked immunosorbent assay using promastigote antigen.